Lincoln Dygert
Optometrist · Ogden, UTNPI 1336175298
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Glaukos Corporation at 36.7% of the total. Reporting peaked in 2020 at $1,079 and has fallen 53.7% since, to $500 in 2025.
Across 39 payments — averaging $72.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$1K
- Coopervision Inc.$607
- Bausch & Lomb Americas Inc.$264
- Biotissue Holdings Inc.$250
- Kala Pharmaceuticals, Inc.$167
- Johnson & Johnson Vision Care, Inc.$157
- plus $353 from 6 others
What the payments were for
- Consulting fees$1,00035%
- Speaking & faculty fees$50018%
- Food & beverage$1,32447%
- Gifts$191%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 3 | $1,044 |
| Coopervision Inc. | 3 | $607 |
| Bausch & Lomb Americas Inc. | 4 | $264 |
| Biotissue Holdings Inc. | 3 | $250 |
| Kala Pharmaceuticals, Inc. | 4 | $167 |
| Johnson & Johnson Vision Care, Inc. | 9 | $157 |
| Alcon | 7 | $137 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $118 |
| AbbVie | 1 | $36 |
| Oyster Point Pharma, Inc. | 1 | $26 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Dompe US, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clariti Contact Lens$500
- Prokera$231
- AmnioGraft$231
- INFUSE$125
- MIEBO$125
- EYSUVIS$122
How this compares
$2,843 in reported general payments places this provider in the 85th percentile of 423 optometrist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 32 | $8,109 |
| Alphagan PBrimonidine Tartrate | 17 | $3,256 |
| CombiganBrimonidine Tartrate/Timolol | 14 | $2,878 |
| Loteprednol Etabonate | 23 | $2,519 |
| Latanoprost | 50 | $538 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Alphagan P, Combigan | $36 | $14,24363 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $118 | $2,51923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 423 optometrist providers in Utah.
Other optometrist in Ogden
- Carrie PalmerOgden$5K
- Stephen ReinhartHill Afb$134K
- Robert WooldridgeMurray$69K
- Ian WhippleFarr West$60K
- Rhett VeaterWest Jordan$52K
- Jonathan KingSouth Ogden$42K
- Collin GrayLehi$30K
- Sean CushmanSalt Lake City$25K
- Brian RowleyPayson$15K
- Michael HillMurray$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.